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Bacterial lipopolysaccharide (LPS) molecules are an important cell surface component that enables
adhesion to surfaces and cell motility, amongst other functions. In Escherichia coli, there aremultiple
Heptosyltransferase enzymes involved in the biosynthesis of the core region of LPS. Here we describe
the ﬁrst ever cloning, expression, puriﬁcation and characterization of Heptosyltransferase III (HepIII)
from E. coli, which catalyzes the addition of an L-glycero-D-manno-heptose (Hep) residue to the grow-
ing LPS core via an a(1? 7) bond. Inspired by results from our lab on the E. coli HepI, we assessed the
catalytic efﬁciency with phospho-Hep2-Kdo2-Lipid A (PH2K2LA) and two deacylated analogues.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lipopolysaccharide (LPS), an abundant biomolecule that is a
major cell surface component of Gram-negative bacteria, is also
an important endotoxin that is recognized for its potential as a gly-
coconjugate or adjuvant for vaccines [1,2]. Multiple labs have
explored the enzymes involved in LPS biosynthesis, including our
own which has focused on the Heptosyltransferases that are
involved in the biosynthesis of the inner core region of LPS [3–7].
Our studies of Heptosyltransferase I (HepI) from Escherichia coli
have revealed that it is the ﬁrst enzyme in the biosynthetic path-
way that does not require lipid functionalization of the Lipid Abased substrate for catalysis [8]. The functional assignment of
Heptosyltransferase III (HepIII) from E. coli was performed by
Whitﬁeld et al. [7], where they determined through gene disrup-
tion studies that HepIII (also known as RfaQ or WaaQ) catalyzes
the formation of an a(1? 7) glycosidic linkage when it transfers
a L-glycero-D-manno-heptose (Hep) to the second Hep of
Hep2-Kdo2-Lipid A after phosphorylation by WaaP (Fig. 1). In an
effort to better understand the similarities and differences of the
Heptosyltransferase enzymes, we herein report the ﬁrst ever clon-
ing and kinetic characterization of HepIII from E. coli. The substrate
scope was explored by assessing catalytic competency of HepIII
with a series of Lipid A analogues. Analyses of
Heptosyltransferase sequence alignments and a newly developed
HepIII structural model were used to inform these ﬁndings. This
work helps shed light on the similarities and differences of the
Heptosyltransferases involved in the LPS inner core biosynthesis,
with potential impact on our understanding of glycosyltransferases
and beyond.2. Materials and methods
All chemicals were purchased at highest purity from Sigma–
Aldrich (St. Louis, MO), unless otherwise indicated.
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Fig. 1. The overall reaction catalyzed by Heptosyltransferase III from E. coli, which involves the transfer of L-glycero-D-manno-heptose from ADP-Hep to the C7 hydroxyl group
of the second heptose of the inner core region of a growing lipopolysaccharide molecule to make an a(1? 7) linkage.
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The E. coli (strain K12) WaaQ gene was PCR ampliﬁed from
genomic DNA and inserted into the plasmid pNGFP-BC (courtesy
of Dr. Eric Gouaux of the Vollum Institute of the Oregon Health &
Science University) using the SalI and BamHI restriction sites using
an In-Fusion Cloning Kit (Clontech Laboratories, Montain View,
CA). The infusion reaction product (N-GFP-HepIII) was transformed
into E. coli DH5a cells, grown overnight at 37 C in LB Gentamycin
(12 mg/L) and Ampicillin (100 mg/L), and the gene sequence in the
resultant plasmid was conﬁrmed by DNA Analysis Facility at Yale
University (New Haven, CT). Each time prior to protein expression,
the pNgfp-HepIII vector was extracted using Zyppy™ plasmid mini
prep kit (Zymo Research, Irvine, CA), and the plasmid was trans-
ferred in to E. coli ArcticExpress cells (Agilent Technologies, Santa
Clara, CA) via heat shock using, 5 lL of extracted plasmid DNA
and 75 lL of ArcticExpress cells. After allowing the cells to recover
in 200 lL of SOC media for one hour at 37 C, the whole culture
was then transferred to a falcon tube containing 20 mL of LB
Gentamycin (12 mg/L) and Ampicillin (100 mg/L), and grown over-
night with shaking at 37 C. The overnight culture was used to
inoculate multiple ﬂasks of LB-Amp media, which were induced
with Isopropyl b-D-1-thiogalactopyranoside (IPTG; Gold
Biotechnology, St. Louis, MO) when the OD600 approached 0.6 AU,
to give a ﬁnal concentration of 1 mM IPTG. Growth was then con-
tinued at 10 C for 24 h.
The cells were pelleted by centrifugation at 5000 rpm, resus-
pended in 25 mL/Lcell cultures of Binding buffer (20 mM HEPES,
1 lM imidazole, 0.5 M NaCl, pH 7.5) containing one cOmplete,
EDTA-free Protease Inhibitor Cocktail Tablets (Roche,
Indianapolis, IN) and lysed using an Emulsiﬂex™-C5 high pressure
homogenizer (Avestin Ottowa, ON) at 15000 psi for three rounds.
Cell debris was removed by centrifugation at 12000 rpm for
30 min and the supernatant was loaded onto a 5 mL Toyopearl
AF Chelate 650 column pre-charged with Cobalt. The column was
then washed with 2 column volumes each of binding buffer and
wash buffer (20 mM HEPES, 40 mM imidazole, 0.5 M NaCl, pH
7.5). The Cobalt was then removed using 4 column volumes of strip
buffer (0.2 M EDTA, 1 M NaCl, and pH 6.8). The fractions containing
pure protein were conﬁrmed by SDS–PAGE gels. Fractions with
HepIII are combined (typically the late wash and strip fractions),
buffer exchanged into the Hep assay buffer (50 mM HEPES,50 mM KCl, 10 mM MgCl2, pH 7.5) and concentrated using a 30
KMWCO Vivaspin 20 (Vivaproducts, Littleton, MA; also available
from GE Healthcare Bio-Sciences, Pittsburgh, PA). The ﬁnal concen-
tration after buffer exchange of the HepIII was determined using a
Bradford assay (standardized against BSA according to kit proto-
cols) and stored at 4 C in the refrigerator for up to three weeks
(efforts to store this enzyme in glycerol containing solutions at
lower temperatures, or as an ammonium sulfate precipitate failed
to support the maintenance of activity). HepIII loses activity and
aggregates slowly over time, necessitating the fresh preparation
of enzyme prior to each set of experiments.
2.2. Synthesis of HepIII substrates and analogues
The E. coli HepIII (WaaQ) deletion strain, CWG297, was gener-
ously provided by Chris Whitﬁeld (University of Guelph). The
HepIII knockout cells were grown in 1 L of LB media containing,
10 lg/mL gentamicin at 37 C overnight, and pelleted by centrifu-
gation at 5000 rpm for 10 min. The phospho-Hep2-Kdo2-Lipid A
(PH2K2LA) was then extracted and deacylated as previously
described [8–10]. Deacylation reaction mixtures were acidiﬁed to
pH 5.5, washed twice using dichloromethane and the aqueous
layer was loaded onto a G-25 size exclusion column (GE) to sepa-
rate the O-deacylated and fully deacylated
phospho-Hep2-Kdo2-Lipid A (subsequently called ODH2LA and
FDH2LA, respectively) from any side products. Products were ana-
lyzed on a Finnigan LCQ Advantage Max ESI-MS (Thermo) as previ-
ously described [8]. LiODH2LA has a molecular weight of
1858.66 Da and an observed (m/z)2 = 929.46 (Fig. S1a) and
NaKFDH2LA has a molecular weight of 1461.21 Da and an
observed (m/z)3 = 487.4 (Fig. S1b).
ADP-L-glycero-D-manno-heptose (ADP-Hep) was isolated from
E. coli WBB06 cells (courtesy of Prof. Christian R.H. Raetz, Duke
University), as previously described [8,11,12], (m/z)1 = 618.05
(Fig. S2).
2.3. HepIII kinetic characterization
The HepIII enzymatic activity with the above substrates was
determined using a CARY 100 Bio UV–vis spectrophotometer
(Agilent technologies) to monitor an ADP/NADH coupled assay at
37 C, analogous to that used for HepI [4,8,13]. The change in the
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response to the conversion of ADP and PEP to ATP and pyruvate by
pyruvate kinase (PK), followed by the conversion of pyruvate and
NADH to lactate and NAD+ by lactate dehydrogenase (LDH). The
assay was performed in buffer containing 50 mM HEPES, 50 mM
KCl, 10 mM MgCl2 and pH 7.5, along with 0.01 units each LDH
and PK, 100 lM NADH, 100 lM PEP. Using a constant concentra-
tion of ADP-Hep (100 lMwhich was predicted to be well in excess
of the Km for APD-Hep based upon the data from HepI and the
afﬁnity of HepIII for its acceptor substrate), and variable concentra-
tions of the sugar acceptor substrates (200 nM to 100 lM), kinetics
were determined for PH2K2LA, ODH2LA and FDH2LA. Assays were
also performed for PH2K2LA and ODH2LA in the presence of 0.1%
Triton X-100 detergent to discern the impact on lipidated sub-
strates. For all the assays, the reactions were started by addition
of HepIII and mixed well using a micropipette after observing a
steady baseline for at least 1 min. The rate data was ﬁtted with
KaleidaGraph to the Michaelis–Menten equation for a triplicate
set of data.
2.4. HepIII structural model generation
Structural models were generated using both Phyre2 [14] and
I-TASSER [15] servers. The resulting structural models (all ﬁve from
I-TASSER and four models generated from Phyre2 with 100.0% con-
ﬁdence ratings) were then compared with both the HepIADP-2-d
eoxy-2-ﬂuoroheptose (pdb id = 2H1H) [13,16] and the
Heptosyltransferase II (HepII, pdb id = 1PSW) structures using the
SALIGN program [17].
2.5. Heptosyltransferase sequence and structure similarity analyses
Initially, amino acid sequences of E. coli Heptosyltransferases I,
II and III were aligned using ClustalW alignment program web-
server with default settings. Based upon the structural alignments
generated above, the ClustalW alignment was modiﬁed to ensure
that the location of gaps and residues were consistent with their
structural superposition, to aid in comparison of the three proteins.
3. Results and discussion
3.1. Soluble expression of HepIII
Determination of conditions for the soluble expression of the
E. coli HepIII was a surprisingly challenging task since both HepI75
50
37
25
(A) 
Fig. 2. SDS page gel analysis of (A) the fractions produced as part of the puriﬁcation of H
HepIII is 38.7kDa, and the N-GFP-HepIII fusion protein is 68.3kDa.and HepII from E. coli had previously been not only functionally
characterized [5,18], but also structurally characterized (HepI
pdb ids = 2GT1, 2H1H and 2H1F; HepII pdb id = 1PSW). In this
work, we explored multiple vectors for the expression of HepIII
(pET-15b, pET-21a, pET-17b and pNGFP-BC, corresponding to an
N-terminal 6-Histitine fusion, a C-terminal 6-Histitine fusion, an
untagged protein and an N-terminal green ﬂuorescent protein
(GFP) fusion, respectively). We also tested a variety of different
bacterial cell lines (E. coli BL21 (DE3) cells – New England
Biolabs, Ipswich, MA; E. coli BL21-AI cells – Life Technologies,
Grand Island, NY; and E. coli Arctic Express cells) with growths
ranging from 5 to 24 h at temperatures ranging from 10 to 37 C.
Only the N-GFP-HepIII fusion protein exhibited soluble expression
when expressed in E. coli Arctic Express cells which were grown at
10 C after induction with ITPG.
As was previously observed by our group for
Heptosyltransferase I, HepIII had high non-speciﬁc afﬁnity to
resins and membranes that were sugar based. As such, attempts
to purify HepIII with a column containing traditional agarose based
afﬁnity column resin would lead to the protein being retained on
the column under all conditions except treatment with 6 M urea.
This protein was, however, able to be successfully puriﬁed by
Histidine tag afﬁnity chromatography using a Toyopearl AF
Chelate column charged with Cobalt, which is a functionalized
non-sugar hydrophilic resin (Fig. 2A). Building off our experience
with HepI, we then selected Vivaspin concentrators because of
their non-sugar polymer components for the concentration of
HepIII. After afﬁnity chromatography and buffer exchanging,
HepIII could be obtained at high purity at concentrations of up to
5.2 mg/mL (Fig. 2B). Once we obtained pure N-GFP-HepIII fusion
protein, multiple attempts were made to cleave off the GFP fusion;
however, all efforts yielded stoichiometric precipitation of HepIII
(the GFP protein stayed soluble). Based upon these results we pro-
ceeded to perform kinetic characterization of the fusion protein
with the recognition that activity might be altered by the presence
of the GFP protein.
3.2. Characterization of HepIII kinetic proﬁles
On the basis of experiments with Heptosyltranferase I (HepI),
we predicted that HepIII might well be able to use a variety of
sugar acceptor (nucleophilic substrate) analogues due to the
expectation that the hydrophobic acyl groups of the growing
Lipid A would endogenously be intercalated into the lipid
membrane. As such, we prepared fully acylated(B) 
epIII and (B) the ﬁnal buffer exchanged and concentrated HepIII fraction. Untagged
Fig. 3. Steady-state kinetic proﬁles of the N-GFP-HepIII fusion protein with (A) PH2K2LA and (B) ODH2LA. Substrate concentrations above 25 lM were not used due to the
high level of noise due to lipid induced light scattering.
Table 1
Steady-state kinetic parameters measured with PH2K2LA and analogous substrates
either in the presence or absence of Triton X-100.
Substrate kcat (s1) Km (lM) kcat/Km (M1 s1)
PH2K2LA 0.41 ± 0.03 10 ± 2 4.1 ± 0.9  104
PH2K2LA + Triton X-100 0.049 ± 0.008 6 ± 3 8.2 ± 4.3  103
ODH2LA 0.028 ± 0.001 0.6 ± 0.1 4.6 ± 0.8  104
ODH2LA + Triton X-100 0.019 ± 0.002 2.4 ± 0.8 7.9 ± 2.8  103
FDH2LA 0.07 ± 0.02 10 ± 5 6.7 ± 4.0  103
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fullydeacylatedanalogue (ODH2LAandFDH2LA, respectively) using
methods analogous to those for puriﬁcation of the Lipid A substrate
of HepI (Fig. 3) [8–10]. We then assessed the catalytic efﬁciency of
each of these substrates with the N-GFP-HepIII fusion protein, in
the presence of 100 lM ADP-Hep (Table 1 and Fig. 4). Additionally,
we assessed the impact of 0.1% Triton X-100 detergent on the kinet-
ics of the fully and partially acylated substrates (PH2K2LA and
ODH2LA), sincewe had observed in HepI an enhancement in overall
catalytic efﬁciency for acylated substrates in the presence of deter-
gent [8].
While we had initially attempted to perform kinetic character-
ization over the concentration range of 200 nM to 100 lM, whenO
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Fig. 4. Structure of the HepIII substrates used in the susing PH2K2LA or ODH2LA we were unable to obtain reliable rate
data above 25 lM due to light scattering caused by micelle forma-
tion or other possible distortions due to the presence of the lipid
tails, consistent with previous reports for the HepI substrate ana-
logues [4]. Using this modiﬁed concentration range, we deter-
mined the kcat/Km for PH2K2LA to be 4.1  104 M1 s1 in the
absence of detergent and 8.2  103 M1 s1 in the presence of
0.1% Triton X-100 (Table 1). This was surprising to us because most
prior work on enzymes involved in LPS biosynthesis have been
observed to have enhanced catalysis in the presence of detergents,
either because of stabilization of the enzyme, or because of favor-
able interactions with the acylated substrates [2,8,19,20].
Alternatively, it is possible, however, that because HepIII acts on
a substrate that is further removed from the membrane than other
previously studied LPS biosynthetic enzymes, that it interacts less
with the membrane and is therefore not stabilized by detergents
which can help encapsulate the Lipid A analogue substrates and
mimic a membrane surface.
Removal of the O-linked acyl groups caused almost no change
in the catalytic efﬁciency for HepIII when compared with the
native acceptor substrate, with a kcat/Km for ODH2LA of 4.6  104
M1 s1 in the absence of detergent and 7.9  103 M1 s1 in the
presence of 0.1% Triton X-100 (Table 1). Interestingly, a greaterO
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Fig. 5. Superposition of the nine HepIII structural models (model1 = tan; model2 = plum; model3 = gray; model4 = dodger blue; model5 = yellow; c2h1fB = light blue;
d1pswA = spring green; c3tovB = coral; c4rapD = deep pink). The C-terminus is on top and the N-terminus is on bottom, with the models depicted looking (A) down the top
Rossmann-like domain and (B) rotated 90.
Fig. 6. Superposition of HepI (pdb id = 2H1H) and HepII (pdb id = 1PSW) with model1 (tan) and c3tovB (coral). The C-terminus is on top and the N-terminus is on bottom,
with the models depicted looking (A) down the top Rossmann-like domain and (B) rotated 45 to accentuate the differences in the prediction for residues 295–320.
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pared to the fully acylated version (corresponding to rates of
0.028 ± 0.001 and 0.41 ± 0.03 s1, respectively) was more than
off-set by compensating decreases in Km. While this decrease in kcat
observed for HepIII is more pronounced than in HepI,
none-the-less the overall catalytic rate for the deacylated substrate
is better when at least some of the acyl groups have been removed.
Further, we determined the kinetic proﬁle for FDH2LA, and
observed that while kcat was reduced as compared to PH2K2LA,
there was not a compensating increase in afﬁnity for the fully dea-
cylated substrate as observed in ODH2LA. We hypothesize that the
negative impact of the newly revealed positive charges on the ami-
nes of FDH2LA could be counteracting any gains in afﬁnity from
removal of preexisting negative interactions between the charged
surface of HepIII with the hydrophobic side chains of PH2K2LA,
making ODH2LA a better substrate overall.3.3. HepIII structure and sequence comparisons
While efforts have been made to crystallize the N-GFP-HepIII
fusion protein, diffraction quality crystals have been elusive. To
aid the interpretation of our kinetic data, multiple structural mod-
els of HepIII were generated using the Phyre2 [14] and I-TASSER
[15] servers (Fig. 5), both of which are top performing programs
in the CASP (Critical Assessment of methods of protein Structure
Prediction) structure prediction competitions [21,22]. All of the
models generated maintained the general GT-B structural architec-
ture, deﬁned as two Rossmann-like domains connected by a typi-
cally alpha-helical linker. When comparing the nine models
generated, the most variable region corresponds to amino acids
295–320, which is alternately deﬁned as a loop, as one or more
alpha helices or a pair of beta strands; these residues correspond
to a short beta strand in HepI and a disordered loop in HepII.
Fig. 7. Sequence alignment of HepI, HepII and HepIII. Residues that are known to be important for catalysis are highlighted in red. Residues that are strictly conserved are
highlighted dark blue and that are similar are in light blue. The regions representing beta strands are indicated by a green bar, and those representing alpha helices are
indicated by a purple bar. The linker region is indicated by a yellow bar.
Fig. 8. Structural representation of model1 showing the Arg and Lys residues that
are clustered together and could represent the regions where the negatively
charged phosphate and carboxylate groups would localize when the sugar acceptor
substrate binds to HepIII. The ﬁrst cluster is composed of residues 54–72 (orange),
the second is composed of residues 93–115 (black), and a third composed of residue
131 in the N-terminus and residues 301–313 from the C-terminus (magenta).
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aligned with both HepI and HepII (pdb ids = 2H1H and 1PSW,
respectively). For two of the nine models (model1 generated by
I-TASSER and model c3tovB generated by Phyre2), the root-mean
square deviation was less than 2.0 Å to both crystal structures
(model1 had an RMSD of 1.32 and 1.86 Å with HepI and HepII,
while c3tovB had an RMSD 1.69 and 1.77 Å with HepI and HepII,
respectively; Fig. 6). Both of these models nicely traced the back-
bone of both Rossmann-like domains and the linker, with the pri-
mary difference being the positioning of the alpha helix and loop
corresponding to residues 295–320.
Based upon the structural alignment of these models with the
previously determined X-ray crystal structures, a protein sequence
alignment was generated from the consensus alignment of these
two models with HepI and HepII (Fig. 7). The N-terminal Asp that
is important for catalysis and the C-terminal residues that are
implicated in coordinating the ADP-Hep are conserved.
Additionally, the relative residue conservation or similarity varies
in each part, with the C-terminus having the most conservation
(likely due to the preserved role of binding ADP-Hep), followed
by the N-terminus, with the linker region being the most variable
(both in residue identity and number of residues). Next, we exam-
ined the N-terminal domain in an attempt to use the structure and
sequence information to predict the binding site of the sugar
acceptor substrate. In particular, upon looking for positively
charged regions that might stabilize the three phosphate residues
or the two carboxylates in PH2K2LA, three clusters of Lys and
Arg residues were identiﬁed (Fig. 8; the ﬁrst composed of residues
54–72, second composed of residues 93–115, and a third com-
posed of residue 131 in the N-terminus and residues 301–313 from
the C-terminus which would be predicted to be proximal as HepIII
undergoes an open-to-closed transition characteristic of the GT-B
superfamily members [4,23,24]). Additionally, it was observed that
there was a greater preponderance of negatively charged residues
in the C-terminal domain, as opposed to the N-terminal domain(the N-terminus has 7 Asp and 4 Glu residues, while the
C-terminus has 13 and 8, respectively). The relative density of pos-
itively charged residues in the N-terminus and the negatively
J. Mudapaka, E.A. Taylor / FEBS Letters 589 (2015) 1423–1429 1429charged residues in the C-terminus, reinforces our hypothesis as to
why the fully deacylated FDH2LA is not as tightly bound as
ODH2LA which is only negatively charged or neutral in various
positions. We hypothesize that the different overall charge states
of the two Rossmann-like domains might help establish a dipole
across the protein reinforcing the likelihood of the N-terminal
domain being pointed toward the membrane to aid in the search
for the membrane bound substrate. Further investigation of
HepIII and other Lipid A derivatizing enzymes could reveal if the
charge distribution pattern is conserved and if it is important for
either the bimolecular association and binding of the sugar accep-
tor substrate.
This work provides the ﬁrst characterization of the
Heptosyltransferase III from E. coli. The enzyme was shown to be
kinetically competent with a variety of sugar acceptor substrates,
with PH2K2LA and ODH2LA having the highest catalytic proﬁ-
ciency. These experiments inform questions about the mechanisms
by which LPS biosynthesis and more speciﬁcally how
Heptosyltransferase enzymes work. Studies further comparing
the three Heptosyltransferases, all of which form different glyco-
sidic bonds using similar enzyme architecture and the same sugar
donor, should be performed in the future so that the chemical and
mechanistic differences can be better understood.Acknowledgements
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